The Centers for Medicare & Medicaid Services announced Monday that Medicaid and CHIP will no longer fund puberty blockers, cross-sex hormones, or sex-change surgeries for children. The rule takes effect October 13, 2026. Seventeen states currently use federal money to cover some degree of these procedures for minors.
That number is about to be zero.
CMS Administrator Dr. Mehmet Oz framed the decision in terms that shouldn't require a medical degree to understand: "Children deserve our protection, not experimental interventions that pose serious risks and convey no proven benefits." He added: "By cutting off federal funds for these sex-rejecting procedures, we're following the science, saving taxpayer dollars, and, most importantly, protecting children from potentially irreversible harm so they can truly flourish."
HHS Secretary Robert F. Kennedy Jr. was more direct. "Today, we are ending federal taxpayer funding for sex-rejecting procedures on children," Kennedy said. "These interventions carry serious risks and can cause irreversible harm."
The rule specifically targets three categories: puberty blockers, cross-sex hormones, and surgical operations. Mental health treatment for gender dysphoria remains fully covered under Medicaid. Children currently receiving hormone treatments get a six-month transition period. States can still fund these procedures with their own money if they choose. The federal government is simply declining to write the check.
HHS Press Secretary Emily Hilliard put the policy in plain terms: "The Trump Administration is drawing a clear line: America's children will not be subjected to life-altering interventions on the taxpayer's dime without reliable evidence of safety and clinical benefit."
The administration cited the UK's Cass Review, conducted by Dr. Hilary Cass and concluded in 2024, which found limited evidence supporting the safety and efficacy of these interventions for minors. That review prompted the UK's National Health Service to restrict the same procedures. Sweden and Finland reached similar conclusions independently. The countries that American progressives usually beg us to emulate already stopped doing this.
The opposition's argument boils down to "access to care" — which is a phrase that does a lot of heavy lifting when the "care" in question involves performing irreversible procedures on children who can't legally buy a beer, rent a car, or sign a contract. Medicaid still covers therapy. It still covers mental health treatment. It covers everything except surgically and chemically altering a child's body based on a diagnosis that the international medical community is actively reconsidering.
A federal judge in Oregon blocked an earlier HHS directive on similar grounds earlier this year. The administration responded by going through formal rulemaking — the administrative procedure route that's significantly harder to overturn in court. They learned from the setback and came back with a version built to survive legal challenge.
Seventeen states were billing the federal government to fund these procedures. Forty-two million children are enrolled in Medicaid and CHIP nationwide. The rule doesn't ban anything. It stops forcing taxpayers in Alabama and Tennessee to subsidize policies that their own state legislatures have already rejected.
The standard the administration is applying — proven safety, demonstrated clinical benefit, reliable evidence — is the same standard applied to every other pediatric medical intervention funded by taxpayers. The only controversy is that someone finally applied it here too.
